Research Partnership launches new patient Living with Ankylosing Spondylitis EU and US 2019 report
Living with ankylosing spondylitis (AS) is a quantitative study conducted online amongst give the total number 365 patients diagnosed with AS in the 5 EU; up to 100 of these will be classified as likely nr-AxSpA in the 5 EU markets (France, Germany, Italy, Spain, UK). In the US, the study is conducted with 105 AS patients and 30 nr-AxSpA patients. The report consists of quantitative 30 minute quantitative online interviews and qualitative tele-depth interviews, and will be published in the 1st quarter 2019.
Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including Axial spondyloarthritis, Psoriatic arthritis and Ankylosing spondylitis, which affects around 1-2% of the global population.
Click here to view our Spondyloarthritis infographic which provides you with an overview of spondyloarthritis patient profiles and treatment pathways.
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »